Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris

Hua Ling; Kathleen A. Packard; Tammy L. Burns; Daniel E. Hilleman

doi:10.1007/s40256-013-0038-z

Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris

Hua Ling, Kathleen A. Packard, Tammy L. Burns, Daniel E. Hilleman

Department of Pharmacy Practice

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	American Journal of Cardiovascular Drugs
Volume	13
DOIs	https://doi.org/10.1007/s40256-013-0038-z
State	Published - Dec 1 2013

Disciplines

Endocrinology, Diabetes, and Metabolism
Cardiology
Internal Medicine
Medicine and Health Sciences

Access to Document

10.1007/s40256-013-0038-zLicense: Unspecified

Cite this

@article{957258cc4a634390a65fc61aaf090a09,

title = "Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris",

author = "Hua Ling and Packard, {Kathleen A.} and Burns, {Tammy L.} and Hilleman, {Daniel E.}",

note = "TY - JOUR T1 - Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris AU - Ling, Hua AU - Packard, Kathleen A. AU - Burns, Tammy L. AU - Hilleman, Daniel E.",

year = "2013",

month = dec,

day = "1",

doi = "10.1007/s40256-013-0038-z",

language = "American English",

volume = "13",

journal = "American Journal of Cardiovascular Drugs",

}

TY - JOUR

T1 - Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris

AU - Ling, Hua

AU - Packard, Kathleen A.

AU - Burns, Tammy L.

AU - Hilleman, Daniel E.

N1 - TY - JOUR T1 - Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris AU - Ling, Hua AU - Packard, Kathleen A. AU - Burns, Tammy L. AU - Hilleman, Daniel E.

PY - 2013/12/1

Y1 - 2013/12/1

UR - https://creighton.pure.elsevier.com/en/publications/impact-of-ranolazine-on-clinical-outcomes-and-healthcare-resource

U2 - 10.1007/s40256-013-0038-z

DO - 10.1007/s40256-013-0038-z

M3 - Article

VL - 13

JO - American Journal of Cardiovascular Drugs

JF - American Journal of Cardiovascular Drugs

ER -

Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris

Disciplines

Access to Document

Other files and links

Cite this